Akshat Jain M.D.,M.P.H.
Medical Director Sickle Cell Center and Gene Therapy
Dr. Akshat Jain is an internationally recognized pediatric hematologist-oncologist and a transformative leader in clinical medicine, global health, healthcare education, and program development. Based at Loma Linda University School of Medicine and Children’s Hospital in California, Dr. Jain specializes in inherited bleeding disorders and hemoglobinopathies, driving advancements in hemophilia and sickle cell disease through cutting-edge gene therapy and precision medicine. His leadership in establishing the Sickle Cell Center of Excellence and the Inherited Bleeding Disorder and Thrombosis Program has revolutionized care for hundreds of patients across California’s Inland Empire. These programs integrate curative therapies like stem cell transplants and novel gene-editing techniques, significantly improving outcomes for complex hematologic conditions.
Dr. Jain’s clinical impact is underscored by his extensive research and leadership in clinical trials. As principal investigator or co-investigator, he has spearheaded pivotal studies, including trials on Wilate for severe Von Willebrand disease, ruxolitinib for pediatric acute lymphoblastic leukemia, and gene-modified cell therapies for sickle cell disease and hemophilia. His Google Scholar profile highlights high-impact publications in journals like *Blood*, *Journal of Pediatric Hematology/Oncology*, and *Haemophilia*, covering topics such as endothelial dysfunction in sickle cell disease, COVID-associated coagulopathy, and immunotherapy for rare blood disorders. Notably, his work on lentiviral vector-based gene therapies and bispecific antibodies has positioned him at the forefront of hematologic innovation, with presentations at prestigious conferences like the American Society of Hematology Annual Meeting.
In global health, Dr. Jain has addressed healthcare disparities in over 17 countries, serving as a consultant to Ministries of Health and an advisor to the World Health Organization. His initiatives through his nonprofit, Prarabdha, have delivered critical medical supplies and public health programs to underserved regions, enhancing access to care for rare diseases. His expertise in women’s health issues related to bleeding disorders has further amplified his global influence, earning him features on international podcasts and media platforms, as noted in his Doximity profile.
Dr. Jain’s contributions to clinical medicine extend to his role as a mentor and educator. At Loma Linda University, he trains medical students and residents, while his global lectures at institutions like Harvard Medical School and Mahatma Gandhi School of Medicine emphasize equitable care and innovation. His accolades, including the 2024 American Society of Hematology Ambassador designation and the 2020 Presidential Physician of the Year Award from the American Association of Physicians of Indian Origin, reflect his profound impact. Dr. Jain’s work continues to bridge clinical excellence, research innovation, and global health equity, shaping the future of hematology.